Pawan Sharma earned his Ph.D. (Parasite Immunology) from CDRI, Lucknow in 1980, and was a Staff Scientist at CDRI till July 1986. He was a PDF at the Research Institute Scripps Clinic, & Visiting Scientist at the Agouron Institute, both in La Jolla, CA, USA. He served at ICGEB, New Delhi as Sr. Res. Scientist & Principal Investigator, from Feb 1989 to Aug 2011. His area of research was Medical Microbiology (TB & Malaria), Molecular Immunology & Cell Biology.
According to the latest research by InsightAce Analytic, the global market for phage therapy was valued at US$ 28.8 Mn and it is expected to reach US$ 116.6 million in 2027, recording a promising CAGR of 19% during the period of 2019-2027. In the current scenario, phage therapy market is not well established with no FDA approved product. Current market is driven by cPT products and natural phage platforms from local vendors such as Microgen Russia and Phage Therapy Centre, Georgia. Strong product pipeline with increasing research and development activities in phage therapy market.
Researchers have discovered that patients with alcoholic hepatitis had high numbers of a destructive gut bacterium and they were able to use a cocktail of phages to target and kill the bacteria, eradicating the disease.